Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3006 |
|
| Actual shortage: | 230 (8%) | |
| Anticipated shortage: | 20 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2747 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-10-02 | 2019-02-06 | 62868 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2018-10-25 | 2018-11-22 | 65602 |
| APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2019-04-18 | 2019-05-13 | 82019 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2019-05-15 | 2019-06-01 | 84112 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-07-31 | 2019-08-19 | 90350 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-08-28 | 2019-12-20 | 92525 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-09-04 | 2019-11-21 | 92989 |
| APO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-10-23 | 2021-09-27 | 97037 |
| APO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-10-23 | 2021-09-20 | 97040 |
| APO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-10-23 | 2021-09-20 | 97043 |
| APO-OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-27 | 2020-03-02 | 99792 |
| APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2019-12-18 | 2020-03-09 | 101517 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2020-03-04 | 2020-04-09 | 107714 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2020-03-18 | 2020-04-09 | 108946 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2020-05-27 | 2020-09-01 | 115972 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2020-06-10 | 2020-06-15 | 117339 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2020-06-10 | 2020-09-01 | 117410 |
| APO-ELETRIPTAN | 40MG | TABLET TABLET | Resolved | 2020-09-02 | 2021-11-19 | 123558 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2020-12-11 | 2021-01-11 | 130065 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2020-12-18 | 2021-03-15 | 130401 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
| APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
| APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
| APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
| APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
| APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 |